Literature DB >> 24877608

Activation of inflammasomes by agents causing idiosyncratic skin reactions: a possible biomarker.

J Kyle Weston1, Jack Uetrecht.   

Abstract

Chemically reactive drugs and drugs that form reactive metabolites often cause idiosyncratic drug reactions (IDRs); however, not all such drugs are associated with IDRs. Most IDRs appear to be immune mediated; therefore, the ability of a drug to induce an immune response may be the determinant of which drugs will cause IDRs. Inflammasome activation plays an important role in the initiation of an immune response. In this study, we studied two pairs of similar chemically reactive drugs, telaprevir/boceprevir and dimethyl fumarate/ethacrynic acid. In both pairs, the drug associated with skin reactions activated inflammasomes in THP-1 cells, and the drug not associated with skin reactions did not.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24877608     DOI: 10.1021/tx5001333

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

1.  Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.

Authors:  Alastair Mak; Ryuji Kato; Kyle Weston; Anthony Hayes; Jack Uetrecht
Journal:  Toxicol Sci       Date:  2018-02-01       Impact factor: 4.849

Review 2.  Non-chemotherapy drug-induced neutropenia: key points to manage the challenges.

Authors:  Brian R Curtis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir.

Authors:  Atiye Toksoy; Helga Sennefelder; Christian Adam; Sonja Hofmann; Axel Trautmann; Matthias Goebeler; Marc Schmidt
Journal:  J Biol Chem       Date:  2017-01-05       Impact factor: 5.157

Review 4.  Inflammasomes and dermatology.

Authors:  Daniel Coelho de Sá; Cyro Festa
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

Review 5.  Mechanistic Studies of Idiosyncratic DILI: Clinical Implications.

Authors:  Jack Uetrecht
Journal:  Front Pharmacol       Date:  2019-07-26       Impact factor: 5.810

Review 6.  NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity.

Authors:  Shanshan Wei; Wanjun Ma; Bikui Zhang; Wenqun Li
Journal:  Front Cell Dev Biol       Date:  2021-04-12

7.  Clozapine Induces an Acute Proinflammatory Response That Is Attenuated by Inhibition of Inflammasome Signaling: Implications for Idiosyncratic Drug-Induced Agranulocytosis.

Authors:  Samantha Christine Sernoskie; Alexandra R Lobach; Ryuji Kato; Alison Jee; Joseph Kyle Weston; Jack Uetrecht
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.